Mice lacking SphK2, but not SphK1, exhibit enhanced brain damage and poorer neurological outcomes after transient middle cerebral artery occlusion, indicating that SPHK2 is a cytoprotective lipid kinase during cerebral ischemia (Pfeilschifter et al., 2011). This evidence concerns the gene SPHK2 and Cerebral ischemia.